Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes

Lian A. van Meijel, Cees J. Tack, Bastiaan E. de Galan*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages8
JournalDiabetes Obesity & Metabolism
DOIs
Publication statusE-pub ahead of print - 16 Aug 2021

Keywords

  • dapagliflozin
  • hypoglycaemia
  • randomized trial
  • SGLT2 inhibitor
  • type 1 diabetes
  • BETA-ADRENERGIC SENSITIVITY
  • OPEN-LABEL
  • INSULIN
  • UNAWARENESS
  • EFFICACY
  • SAFETY
  • RESPONSES
  • RISK

Cite this